Biopharmaceutical Research Companies Are Developing More Than 85 Medicines for Alzheimer’s Disease

December 19, 2017

According to a new report, the amount of American lives altered by Alzheimer’s disease (AD) continues to grow. Researchers discovered that roughly 5+ million Americans had Alzheimer’s or mild cognitive impairment (MCI) as a result of the disease in 2017. The report also revealed that 16 million people will be living with Alzheimer’s by 2050.

Medicines in Dev_2.JPG